Harbin Pharmaceutical Group Co., Ltd. (600664.SS)

CNY 3.97

(0.0%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 14.11 Billion 13.43 Billion 12.84 Billion 11.84 Billion 12.5 Billion 11.9 Billion
Total Current Assets 10.39 Billion 9.55 Billion 8.73 Billion 7.8 Billion 7.3 Billion 7.2 Billion
Cash And Short Term Investments 3.06 Billion 2.43 Billion 1.59 Billion 896.99 Million 675.5 Million 2.04 Billion
Cash and Cash Equivalents 3.06 Billion 2.43 Billion 1.59 Billion 896.99 Million 675.5 Million 2.04 Billion
Short Term Investments - -47.86 Million -65.11 Million -78.47 Million -87.91 Million -93.3 Million
Net Receivables 5.18 Billion 5.25 Billion 5 Billion 4.96 Billion 4.55 Billion 3.43 Billion
Inventory 1.92 Billion 1.8 Billion 2.06 Billion 1.86 Billion 2.02 Billion 1.68 Billion
Other Current Assets 225.88 Million 64.34 Million 75.68 Million 83.92 Million 46.68 Million 35.54 Million
Total Non-Current Assets 3.71 Billion 3.87 Billion 4.1 Billion 4.03 Billion 5.19 Billion 4.69 Billion
Net PPE 2.46 Billion 2.64 Billion 2.83 Billion 2.78 Billion 3.06 Billion 3.37 Billion
Good Will And Intangible Assets 517.38 Million 530.91 Million 569.71 Million 525.36 Million 527.77 Million 550.01 Million
Good Will 39.14 Million 39.14 Million 39.14 Million - - -
Intangible Assets 478.23 Million 491.76 Million 530.56 Million 525.36 Million 527.77 Million 550.01 Million
Long-Term Investments 103.08 Million 85.48 Million 104.42 Million 127.19 Million 1.19 Billion 437.67 Million
Tax Assets 597.85 Million 601.32 Million 599.44 Million 602.85 Million 413.31 Million 334.76 Million
Other Non Current Assets 29.69 Million 17.37 Million 974 Thousand 974 Thousand 974 Thousand 974 Thousand
Other Assets - 1.00 - 1.00 1.00 -
Total Liabilities 8.37 Billion 8.48 Billion 8.42 Billion 7.85 Billion 6.55 Billion 5.61 Billion
Total Current Liabilities 8.24 Billion 8 Billion 7.85 Billion 7.3 Billion 6.06 Billion 5.09 Billion
Account Payables 2.28 Billion 3.5 Billion 3.48 Billion 3.66 Billion 3.72 Billion 3.13 Billion
Tax Payables 80.1 Million 212.02 Million 144.15 Million 98.33 Million 151.57 Million 93.29 Million
Short Term Debt 3.49 Billion 2.08 Billion 2.21 Billion 1.73 Billion 635.92 Million 215.31 Million
Deferred Revenue 282.44 Million 235.87 Million 1.96 Billion 1.84 Billion 1.55 Billion 93.29 Million
Other Current Liabilities 2.18 Billion 2.17 Billion 189 Million 59.19 Million 157.13 Million 1.65 Billion
Total Non Current Liabilities 127.25 Million 483.17 Million 567.18 Million 552.17 Million 491.11 Million 526.69 Million
Long-Term Debt 32.62 Million 76.87 Million 95.69 Million 36.7 Million 37.15 Million 38.86 Million
Deferred Revenue Non Current 319.07 Million 333.61 Million 375.1 Million 407.81 Million 429.49 Million 461.51 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -231.36 Million 69.7 Million 94.7 Million 106.04 Million 23 Million 2.94 Million
Other Liabilities 1.00 1.00 - 1.00 - 1.00
Total Equity 5.42 Billion 4.95 Billion 4.42 Billion 3.98 Billion 5.94 Billion 6.28 Billion
Stock Holders Equity 4.72 Billion 4.33 Billion 3.84 Billion 3.47 Billion 5.45 Billion 5.86 Billion
Common Stock 2.52 Billion 2.52 Billion 2.51 Billion 2.5 Billion 2.5 Billion 2.54 Billion
Retained Earnings 1.99 Billion 1.6 Billion 1.14 Billion 769.22 Million 1.84 Billion 1.74 Billion
Accumulated other comprehensive income -69.81 Million -74.56 Million -68.93 Million -49.91 Million 849.09 Million 1.24 Billion
Common Stock Equity 4.72 Billion 4.33 Billion 3.84 Billion 3.47 Billion 5.45 Billion 5.86 Billion
Capital Lease Obligation 31.07 Million 43.68 Million 61.6 Million 34.45 Million - -
Total Investments 103.08 Million 37.62 Million 39.31 Million 48.72 Million 1.1 Billion 344.37 Million
Total Debt 3.55 Billion 2.15 Billion 2.31 Billion 1.77 Billion 673.08 Million 254.18 Million
Net Debt 498.52 Million -276.42 Million 720.94 Million 876.71 Million -2.41 Million -1.79 Billion

Balance Sheet Charts